mmol) in ether (20 cm3) was reduced with lithium aluminium
hydride (2.40 g, 63 mmol) in ether (80 cm3) to yield the alcohol
5b (1.9 g, 80%) as a colourless oil; νmax (film)/cmϪ1 3400 and
δ (120 MHz; CDCl ) 150.1 (C᎐N), 149.3 (α-pyr), 137.5 (γ-pyr),
᎐
C 3
125.1 (β-pyr), 69.6 (CHOH), 44.6 (CH2), 42.0 (br, CoCH2), 38.5
(CMe2), 29.9 (Me), 29.8 (Me), 12.2 (dmgMe2), 12.1 (dmgMe2)
[NB the expected resonance for CD2OH was not identified]; m/z
(FAB) 502 (MHϩ), 423, 422, 368, 290 (100%), 289.
1050; δH (200 MHz; CDCl ) 5.73–5.83 (1H, br t, ᎐CH), 3.27
᎐
3
(2H, s, CH2O), 1.96 (2H, d, CH2), 1.88 (1H, br s, OH), 0.84 (6H,
s, Me2); m/z (EI) 117.1241 (MHϩ, C7H132H2O requires
117.1248), 117 (15%), 116 (5), 73 (100), 43 (95).
1-[tert-Butyl(dimethyl)silyloxy]-2,2-dimethylpent-4-ene 12
2,2-Dimethylpent-4-en-1-ol 5a (13.7 g, 0.1 mol), tert-
butyldimethylsilyl chloride (25.0 g, 0.2 mol) and imidazole (11.3
g, 0.2 mol) in dimethylformamide (100 cm3) were stirred under
a nitrogen atmosphere overnight (18 h). Work-up was carried
out in the usual manner.29 The crude product was purified by
flash column chromatography (light petrol) and the solvent was
removed to yield the title compound 12 (27.4 g, 100%) as a
colourless liquid; νmax (film)/cmϪ1 2957, 1641 and 1257; δH (200
[1,1-2H2]-5-Bromo-4,4-dimethylpent-1-ene 6b
This compound was synthesised from [5,5-2H2]-2,2-
dimethylpent-4-en-1-ol 5b in the manner of 6a (1.9 g, 50% by
NMR analysis); νmax (film)/cmϪ1 2924 and 1653; δH (200 MHz;
CDCl ) 5.69–5.78 (1H, br t, ᎐CH), 3.25 (2H, s, CH Br), 2.07
᎐
3
2
(2H, d, CH2, J 7.5), 0.99 (6H, s, Me2); m/z (EI) 178 (5%, Mϩ),
135 (60), 99 (64), 55 (100).
MHz; CDCl ) 5.68–5.89 (1H, m, RCH᎐), 4.92–4.97 (2H, m,
᎐
3
[3,3-2H2]-2-(3-Bromo-2,2-dimethylpropyl)oxirane 7b
᎐CH ), 3.20 (2H, s, CH O), 1.96 (2H, dt, CH , J 4.3 and 1.10),
᎐
2
2
2
t
0.87 (9H, s, Bu), 0.80 (6H, s, Me2), 0.07 (6H, s, SiMe2); δC (50
MHz; CDCl ) 135.8 (RC᎐), 116.7 (᎐CH ), 71.3 (CH O), 43.2
[3,3-2H2]-2-(3-Bromo-2,2-dimethylpropyl)oxirane 7b was syn-
thesised from [1,1-2H2]-5-bromo-4,4-dimethylpent-1-ene 6b in
the manner of 7a. Distillation under reduced pressure (bp 42 ЊC
at 0.3 mmHg) yielded the deuteriated bromo epoxide 7b (1.1 g,
52%) as a colourless oil; νmax (film)/cmϪ1 3046, 1267 and 663;
δH (200 MHz; CDCl3) 3.37 (1H, d, CHBr, J 10.1), 3.32 (1H, d,
CH’Br, J 10.1), 2.93 (1H, dd, CHO, J 4.7 and 7.2), 1.6–1.75
(1H, dd, CH, J 4.7 and 14.3), 1.45 (1H, dd, CHЈ, J 7.2 and
14.3), 1.1 (6H, s, Me2); δC (50 MHz; CDCl3) 48.2 (CH2Br), 46.4
(CH2), 42.7 (CH), 34.6 (CMe2), 26.2 (Me2).
᎐
᎐
3
2
2
(CH2), 35.6 (CMe2), 26.0 (SiCMe3), 24.0 (Me2), 18.3 (SiCMe3),
Ϫ5.5 (SiMe2); m/z (EI) 228 (10%, Mϩ), 97 (45).
1-[tert-Butyl(dimethyl)silyloxy]-2,2-dimethylpentan-5-ol 1330,31
Hydroboration of 1-[tert-butyl(dimethyl)silyloxy]-2,2-dimethyl-
pent-4-ene 12 (2.05 g, 9.0 mmol) in tetrahydrofuran (10 cm3) was
achieved with disiamylborane (1,2-dimethylpropylborane).30
Work-up and oxidation was carried out using the procedure of
Brown et al.31 The crude product was purified by flash column
chromatography (CH2Cl2) to yield the alcohol 13 (1.7 g, 82%)
as a colourless oil; δH (200 MHz; CDCl3) 3.59 (2H, t, CH2OH,
J 6.7), 3.22 (2H, s, CH2OSi), 1.67 (1H, br s, OH), 1.50–1.61
[5,5-2H2]-4-(3-Bromo-2,2-dimethylpropyl)-2,2-dimethyl-1,3-
dioxolane 8b
This was synthesised from [3,3-2H2]-2-(3-bromo-2,2-
dimethylpropyl)oxirane 7b in the manner of 8a to yield the
deuteriated bromo acetal 8b (0.84 g, 53%) as a colourless oil; δH
(200 MHz; CDCl3) 4.1 (1H, dd, CHO), 3.3 (2H, s, CH2Br), 1.6–
1.8 (1H, dd, CH2, J 14.2 and 7.8), 1.4–1.6 (1H, dd, CH2, J 14.2
and 4.0), 1.35 (3H, s, Me), 1.30 (3H, s, Me), 1.1 (3H, s, Me),
1.06 (3H, s, Me); δC (50 MHz; CDCl3) 108.9 (O2CMe2), 73.1
(CH), 46.8 (CH2Br), 43.2 (CH2), 34.4 (CMe2), 27.0 (Me), 26.8
(Me), 26.1 (Me), 26.0 (Me).
t
(2H, m, CH2), 1.11–1.48 (2H, m, CH2), 0.87 (9H, s, Bu), 0.81
(6H, s, Me2), 0.00 (6H, s, SiMe2); δC (50 MHz; CDCl3) 71.4
(CH2OH), 63.9 (CH2OSi), 35.0 (CMe2), 34.5 (CH2), 27.4 (CH2),
25.9 (Me2), 24.1 (tBu), 18.3 (SiCMe3), Ϫ5.5 (SiMe2).
5-[tert-Butyl(dimethyl)silyloxy]-4,4-dimethylpentanal 14
Swern oxidation of 1-[tert-butyl(dimethyl)silyloxy]-2,2-
dimethylpentan-5-ol 13 (3.78 g, 15.4 mmol) in DCM (10 cm3)
with oxalyl chloride (2.2 g, 1.5 cm3, 17 mmol) and dimethyl
sulfoxide (2.6 g, 2.4 cm3, 34 mmol) in DCM (45 cm3) at
Ϫ78 ЊC,32 followed by flash column chromatography (CH2Cl2)
of the crude product, yielded the aldehyde 14 (2.0 g, 53%) as a
colourless oil; νmax (film)/cmϪ1 2930 and 1713; δH (200 MHz;
CDCl3) 9.73 (1H, br t, CHO), 3.22 (2H, s, CH2O, 2.33–2.40
(2H, m, CH2CH2CHO), 1.5–1.7 (2H, t, CH2CH2CHO, J 8.2),
0.86 (9H, s, tBu), 0.82 (6H, s, Me2), Ϫ0.01 (6H, s, SiMe2).
[5,5-2H2]-4,5-Dihydroxy-2,2-dimethyl-4,5-di-O-isopropylidene-
pentyl(pyridine)bis(dimethylglyoximato(1؊)-N,NЈ)cobalt 9b
This was synthesised from [5,5-2H2]-4-(3-bromo-2,2-dimeth-
ylpropyl)-2,2-dimethyl-1,3-dioxolane 8b in the manner of 9a to
yield the deuteriated alkyl-cobaloxime 9b (0.12 g, 35%) as
orange plates; νmax (disc)/cmϪ1 2955 and 1240; δH (200 MHz;
CDCl3) 8.5 (2H, m, α-pyr), 7.65 (1H, t, γ-pyr), 7.25 (2H, t,
β-pyr), 3.31 (1H, s, CHO), 2.07 (6H, s, dmgMe2), 2.06 (6H, s,
dmgMe2), 1.92 (1H, d, CoCH2, J 8.8), 1.55 (1H, d, CoCH2,
J 8.8), 1.4 (2H, m, CH2), 1.34 (3H, s, Me), 1.30 (3H, s, Me), 0.77
(3H, s, Me), 0.73 (3H, s, Me); δC (50 MHz; MeOH) 150.7
1-[tert-Butyl(dimethyl)silyloxy]-5-hydroxy-2,2-dimethyl-6-
nitrohexane 1533
5-[tert-Butyl(dimethyl)silyloxy]-4,4-dimethylpentanal 14 (2.01
g, 8.2 mmol) and nitromethane (0.50 g, 8.2 mmol) in ethanol
(4 cm3) were cooled in an ice bath and sodium hydroxide
solution (0.9 cm3, 10 M, 9 mmol) was added dropwise over 30
min. The reaction mixture was stirred for 3 h on an ice bath
then acetic acid solution (10 cm3, 1 M) was added. The ethanol
was removed under reduced pressure and the aq. residue was
extracted with ethyl acetate. The combined organic extracts
were washed with sodium hydroxide solution (0.1 M), brine,
and dried. Removal of the solvent and purification of the
residue by flash column chromatography (CH2Cl2) gave the
nitro alcohol 15 (1.8 g, 77%) as a colourless oil; νmax (film)/cmϪ1
3435, 2955, 1556, 1363 and 1099; δH (200 MHz; CDCl3) 4.3–4.5
(2H, m, CH2NO2), 4.1–4.3 (1H, m, CHOH), 3.2 (2H, s,
CH2OSi), 2.4 (1H, br s, OH), 1.2–1.6 (4H, m, CH2CH2), 0.89
(9H, s, tBu), 0.88 (6H, s, Me2), 0.02 (6H, s, SiMe2); δC (50 MHz;
CDCl3) 80.6 (CH2NO2), 71.1 (CH2OH), 69.5 (CH2OSi), 35.0
(CMe2), 33.9 (CHOHCH2), 28.5 (CHOHCH2CH2), 25.9 (OSi-
(C᎐N), 149.1 (α-pyr), 139.8 (γ-pyr), 126.9 (β-pyr), 110.4
᎐
(O2CMe2), 75.6 (CHO), 45.2 (CH2), 35.5 (CMe2), 27.7 (Me),
27.4 (Me), 26.7 (Me), 26.6 (Me), 12.7 (dmgMe4) [NB the
expected resonance for CD2OH was not identified]; m/z (FAB)
542 (MHϩ), 541, 463, 290.
[5,5-2H2]-4,5-Dihydroxy-2,2-dimethylpentyl(pyridine)bis-
(dimethylglyoximato(1؊)-N,NЈ)cobalt 1b
This compound was prepared from 9b in the manner of 1a to
give the deuteriated diol-cobaloxime 1b (75 mg, 57%) as orange
plates; νmax (disc)/cmϪ1 3410 br, 2928, 1562, 1446 and 1237;
δH (500 MHz; CDCl3) 8.5–8.55 (2H, d, α-pyr), 7.75 (1H, t,
γ-pyr), 7.25 (2H, t, β-pyr), 3.5 (1H, br t, CHOH, J 5.1), 2.22
(6H, s, dmgMe2), 2.15 (6H, s, dmgMe2), 2.07–2.10 (1H, d, CH-
Co, J 11.0), 1.45–1.55 (1H, d, CHЈ-Co, J 11.0), 1.4 (1H, m,
CH2), 1.2 (1H, m, CHЈ2), 0.8 (3H, s, CH3), 0.65 (3H, s, CH3);
4494
J. Chem. Soc., Perkin Trans. 1, 2000, 4488–4498